ThursdayJun 29, 2017 3:59 pm

Future Farm Technologies, Inc. (CSE: FFT) (OTCQB: FFRMF) Launches Its New and Expanded Interactive Website

LED lighting producer and leading indoor plant growth solutions provider Focused on efficiencies for the legal cannabis industry Website is now SEO-optimized, providing an easier way to order product Future Farm Technologies, Inc. (CSE: FFT) (OTCQB: FFRMF) has fully updated and SEO-optimized its e-commerce website (www.LEDCanada.com) in response to rising consumer demand for LED grow lights. The new and expanded site has gone live, and the LED product line can be viewed on LEDCanada.com. The site now contains a number of social media buttons for Facebook, Twitter, and Pinterest. The LEDCanada.com website will be updated with the newest content from…

Continue Reading

TuesdayJun 27, 2017 2:27 pm

Invictus MD (OTC: IVITF) (TSX.V: IMH): A Cannabis Company Living Up to its Name

Canadian Cannabis Valuations up 200% in two years 250 acres of cultivation space stretching from Alberta to Ontario Paid out $1,000,000 in Dividends representing $0.07 per Share It might just be that Invictus MD Strategies Corp. (OTC: IVITF) (TSX.V: IMH) (FRA: 8IS) has adopted as a motto the elevating penultimate line from William Ernest Henley’s immortal poem Invictus: “I am the master of my fate”. Canada’s Cannabis Company appears completely unafraid as it ploughs ahead with its strategy to become a dominant company in Canada’s cannabis space. That boldness is paying off; Invictus is one of only a handful of…

Continue Reading

MondayJun 26, 2017 2:52 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Targeting Blockbuster Therapeutics

The medical efficacy of cannabinoids to treat a multiplicity of maladies is no longer in doubt. Two recently published scientific studies dispelled any apprehensions about cannabis-based therapies. The highly respected New England Journal of Medicine published a peer reviewed article that proved in a controlled study that cannabidiol dramatically reduced the number of convulsive seizures in children stricken with a severe epileptic disorder (http://nnw.fm/i0X0D). The results of this study follow a comprehensive report by the National Academies of Science, Engineering, and Medicine which confirmed that cannabinoids are effective at treating chronic pain and for providing relief from nausea and vomiting…

Continue Reading

ThursdayJun 22, 2017 3:41 pm

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) Takes Additional Step toward Clinical Trials for INM-750

Moving toward offering the very first therapy for treating epidermolysis bullosa (EB), InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) recently announced it has signed an agreement with Pharmaseed Ltd. (http://nnw.fm/4lZzC) to develop a final formulation for INM-750, InMed’s lead compound, which is being developed as a therapy for EB and for other potential dermatological and wound-healing applications. EB is a group of inherited connective tissue diseases sharing a common manifestation of very fragile skin that is prone to easily blistering or tearing. An orphan disease that currently has no approved treatments and has significant unmet medical need, EB results from…

Continue Reading

MondayJun 05, 2017 8:00 am

ABcann Global (TSXV: ABCN) Target Price Set At $2.25 as Coverage is Initiated

Now that shares of ABcann Global Corporation (TSXV: ABCN) are trading on the venture arm of the Toronto Stock Exchange (TSX), the company is creating more buzz than ever. On the same day it launched its initial public offering (IPO) (May 4), industry analysts PI Financial initiated coverage of the stock with a decidedly bullish report (http://nnw.fm/zcgG2) on the company. PI has put a “Buy” rating on the stock and set a one-year price target of $2.25, implying a return of well over 100 percent. The investment bank backs up this sunny prognosis with an in-depth look at ABcann’s value…

Continue Reading

ThursdayJun 01, 2017 8:43 am

ABcann Medicinals (TSXV: ABCN) Eyes Growing Role on Canadian Marijuana Market, Extends Agreement with MMJ Pioneer

One of the most dominant and experienced growers of quality medical marijuana on the Canadian market, ABcann Medicinals (TSXV: ABCN), has entered a stage of aggressive growth after launching its first initial public offering (IPO) on the TSX Venture Exchange earlier this month. Recently acquired by ABcann Global Corporation, an acquisition that came with a $26.8 million capital raise to help expand production, the company is already licensed to sell to the entire Canadian market and plans to significantly expand production to reach this goal. In addition, ABcann also plans to sign partnerships to sell to the U.S. market, as…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977